{"Title": "Optimising psychotropic medication prescribing to reduce adverse drug events", "Year": 2019, "Source": "J. Intellect. Disabil. Res.", "Volume": "63", "Issue": 5, "Art.No": null, "PageStart": 369, "PageEnd": 371, "CitedBy": 0, "DOI": "10.1111/jir.12625", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85064478802&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Behavioral Symptoms", "Drug Prescriptions", "Drug-Related Side Effects and Adverse Reactions", "Humans", "Intellectual Disability", "Psychotropic Drugs"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 0, "EID": "2-s2.0-85064478802", "SubjectAreas": [["Rehabilitation", "MEDI", "2742"], ["Arts and Humanities (miscellaneous)", "ARTS", "1201"], ["Neurology", "NEUR", "2808"], ["Neurology (clinical)", "MEDI", "2728"], ["Psychiatry and Mental Health", "MEDI", "2738"]], "AuthorData": {"56079439400": {"Name": "Strydom A.", "AuthorID": "56079439400", "AffiliationID": null, "AffiliationName": null}, "7006330146": {"Name": "Melville C.", "AuthorID": "7006330146", "AffiliationID": null, "AffiliationName": null}}}